Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
APGE
#1334
Apogee Therapeutics, Inc. Common Stock
89.320
0
USD
+0.96%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.96%
Aylık Değişim
+24.04%
6 aylık değişim
+66.67%
Yıllık Değişim
+66.67%
Önceki Kapanış
88.470
0
Open
89.320
0
Bid
Ask
Low
89.320
0
High
89.320
0
Hacim
74
Piyasalar
ABD Borsası
Sağlık Hizmetleri
APGE
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
46.02 M
46.05 M
46.11 M
68.32 M
56 M
—
Valuation ratios
Enterprise value
1.94 B
1.61 B
1.88 B
2.61 B
4.1 B
10.19 B
Price to earnings ratio
-13.73
-10.35
-10.49
-9.05
-17.89
-47.78
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-14.61
-11.23
-11.22
-9.82
-20.14
-52.41
Price to book ratio
3.49
0.73
0.9
0.88
5.07
7.58
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.09
-0.08
-0.1
-0.1
-0.07
-0.36
Return on equity %
-0.09
-0.08
-0.11
-0.11
-0.08
-0.38
Return on invested capital %
-128.58
-119.2
-171.22
-242.05
-215.94
-748.4
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
18.55
15.82
16.36
15.86
26.57
74.61
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.23
-0.83
-1.06
-0.92
-1.03
-3.85
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
9.43
8.82
8.65
8.97
12.03
38.47
Net current asset value per share
9.6
8.96
8.83
9.19
12.22
39.2
Tangible book value per share
12.99
11.57
10.6
9.98
14.89
47.04
Working capital per share
9.08
8.4
8.29
8.61
11.76
37.05
Book value per share
12.99
11.57
10.6
9.98
14.89
47.04
Haberler
Spyre Therapeutics Flies On Takeda-Rivaling Ulcerative Colitis Results
Apogee Therapeutics CEO’su 1,65 milyon dolarlık hisse sattı
Apogee Therapeutics hissesi 85,95 dolarda zirve yaptı
Apogee Therapeutics CMO 466.619 dolarlık hisse sattı
Apogee Therapeutics CFO’su 170 bin dolarlık hisse sattı
Why Delta, Starbucks and these other stocks were just added to a market-beating ‘fresh money’ list
BTIG, Apogee Therapeutics hissesi için Al tavsiyesini yineledi
Mizuho, AD verileriyle Apogee hisse hedefini yükseltti
Apogee Therapeutics CFO’su Henderson 170 bin dolarlık hisse sattı
Apogee Therapeutics hisse arzından 403 milyon dolar topladı
Apogee Therapeutics 377,4 milyon dolarlık halka arz açıkladı
Apogee Therapeutics hissesi 84,56 dolarda rekor kırdı